Hexokinase is inhibited by?
Which of the following is the major glycosaminoglycan of synovial fluid?
Which of the following is NOT required for gluconeogenesis from lactate?
Which of the following statements about GLUT 2 transporters is correct?
What is the main enzyme involved in glycogen breakdown (glycogenolysis)?
The energy for glycogenesis is provided by -
Gluconeogenesis occurs in all except:
Inhibition of glycolysis by increased supply of O2 is called ?
What is the maximum value on the glycemic index scale that classifies a food as low glycemic index?
Which of the following substances does not inhibit glycolysis?
Explanation: ***Glucose-6-phosphate (G6P)*** - Hexokinase is subject to **feedback inhibition** by its product, **glucose-6-phosphate**, preventing the accumulation of high levels of G6P inside the cell. - This regulatory mechanism ensures that glycolysis does not proceed unchecked when energy needs are met or when G6P levels are already sufficient. *Glucagon* - **Glucagon** is a hormone that generally promotes **glucose production** and release, primarily by stimulating gluconeogenesis and glycogenolysis, rather than directly inhibiting hexokinase. - Its effects on glucose metabolism are more about increasing blood glucose levels than directly regulating the initial step of glycolysis in most tissues. *Glucose* - **Glucose** is the **substrate** for hexokinase, meaning it is the molecule that hexokinase acts upon to convert it into glucose-6-phosphate. - Therefore, glucose does not inhibit hexokinase; instead, its presence is necessary for the enzyme's activity. *Insulin* - **Insulin** is a hormone that promotes **glucose uptake** and utilization by cells, often by increasing the number of glucose transporters on cell surfaces. - While insulin can indirectly influence glycolysis by increasing glucose availability, it does not directly inhibit hexokinase; rather, it generally supports cellular glucose metabolism.
Explanation: ***Hyaluronic acid*** - **Hyaluronic acid** is the primary glycosaminoglycan in **synovial fluid**, providing its characteristic **viscosity** and **lubricating properties**. - It plays a crucial role in maintaining **joint health** by reducing friction and acting as a shock absorber. *Chondroitin sulfate* - **Chondroitin sulfate** is abundant in **cartilage**, contributing to its **compressive strength**. - While present in connective tissues, it is not the major glycosaminoglycan of synovial fluid. *Dermatan sulfate* - **Dermatan sulfate** is primarily found in **skin**, **blood vessels**, and **heart valves**. - Its main roles involve tissue structure and repair, not lubrication of synovial fluid. *Heparan sulfate* - **Heparan sulfate** is found on **cell surfaces** and in the **extracellular matrix**, especially in the **basement membranes**. - It regulates cell growth, adhesion, and signaling, and is not a major component of synovial fluid viscosity.
Explanation: ***Transamination of pyruvate to alanine*** - While **alanine** can be a substrate for gluconeogenesis, **lactate** is directly converted to pyruvate, which then enters the gluconeogenesis pathway. **Transamination to alanine** is not a required intermediate step for lactate-derived glucose production. - The direct conversion of **lactate to pyruvate** by **lactate dehydrogenase** is the key initial step, not its conversion to alanine. *Transport of lactate from muscle to liver* - **Lactate** produced in muscles (e.g., during intense exercise) must be transported to the **liver** via the bloodstream to be used for **gluconeogenesis** in the **Cori cycle**. - This transport is essential for clearing lactate from the periphery and supplying the liver with a gluconeogenic precursor. *Conversion of lactate to pyruvate* - **Lactate dehydrogenase** catalyzes the reversible conversion of **lactate to pyruvate**, which is the critical first step in converting lactate into a gluconeogenic substrate. - This reaction regenerates **NAD+** (not NADH), which is necessary for glycolysis to continue in muscle tissue. *None of the above* - This option is incorrect because there IS a step listed above that is not required: **transamination of pyruvate to alanine** is indeed not necessary for gluconeogenesis from lactate, making Option A the correct answer to this "NOT required" question.
Explanation: ***Insulin independent*** - GLUT2 transporters facilitate glucose transport into cells **regardless of insulin levels**, making them crucial for basal glucose sensing and transport functions. - This **insulin independence** is vital for organs like the liver and pancreatic beta cells to respond to varying glucose concentrations. *Insulin dependent* - **Insulin-dependent** transporters, such as **GLUT4**, respond to insulin by relocating to the cell membrane to increase glucose uptake. - This characteristic applies to tissues like **skeletal muscle** and **adipose tissue**, not GLUT2. *Found in cardiac muscle* - **Cardiac muscle** primarily utilizes **GLUT4** for glucose uptake, which is insulin-dependent. - While other GLUT transporters might be present in cardiac tissue, **GLUT2** is not the primary mechanism for glucose transport here. *Found in brain* - The **brain** predominantly uses **GLUT1** and **GLUT3** for glucose transport, which have **high affinity** for glucose to ensure constant supply. - **GLUT2** is not a primary transporter of glucose in the brain.
Explanation: ***Glycogen phosphorylase*** - This is the **rate-limiting and primary enzyme** for **glycogenolysis**, the breakdown of glycogen into glucose units. - It cleaves **α-1,4-glycosidic bonds** in glycogen, releasing **glucose-1-phosphate** units. - Regulated by both **allosteric mechanisms** and **hormonal control** (epinephrine, glucagon). - Works until it reaches 4 glucose residues from a branch point, where debranching enzyme takes over. *Glycogen synthase* - This is the main enzyme for **glycogenesis** (glycogen synthesis), not breakdown. - It catalyzes formation of α-1,4-glycosidic bonds to build glycogen chains. - This is the opposite direction of metabolism from what the question asks about. *Glucose-6-phosphatase* - This enzyme is involved in **gluconeogenesis** and the final step of converting **glucose-6-phosphate to free glucose**. - It is NOT directly involved in glycogen breakdown itself, but rather in the subsequent conversion pathway. - Found primarily in **liver and kidney** to release free glucose into blood. *Hexokinase* - This enzyme phosphorylates free glucose to **glucose-6-phosphate** (opposite direction). - It is involved in **glucose utilization**, not glycogen breakdown. - It traps glucose inside cells for metabolism or glycogen synthesis.
Explanation: ***UTP*** - **Uridine triphosphate (UTP)** is essential for **glycogenesis** as it activates glucose by forming **UDP-glucose** from glucose-1-phosphate. - The reaction (Glucose-1-P + UTP → UDP-glucose + PPi) creates a **high-energy intermediate** that drives glycogen synthesis. - The subsequent hydrolysis of pyrophosphate (PPi) makes this activation step **irreversible**, and the energy stored in UDP-glucose is used for **glycosidic bond formation** when glucose is added to the growing glycogen chain. *GTP* - **Guanosine triphosphate (GTP)** is primarily involved in **protein synthesis**, G-protein signaling, and the citric acid cycle. - It is not used for glucose activation in glycogenesis; that role is specific to **UTP**. *GDP* - **Guanosine diphosphate (GDP)** is a product of GTP hydrolysis and functions in regulatory processes. - It does not serve as an energy donor for glycogen synthesis. *AMP* - **Adenosine monophosphate (AMP)** is a low-energy signal molecule that indicates cellular energy depletion. - High AMP levels **inhibit glycogenesis** and activate glycogenolysis through allosteric regulation of key enzymes. - It does not provide energy for anabolic pathways like glycogen synthesis.
Explanation: ***Muscle*** - **Muscle tissue** lacks the enzyme **glucose-6-phosphatase**, which is essential for releasing free glucose into the bloodstream during gluconeogenesis. - While muscle can store glycogen, it primarily uses glucose for its own energy needs and does not contribute significantly to systemic glucose homeostasis through gluconeogenesis. *Liver* - The **liver** is the primary site of **gluconeogenesis**, producing glucose to maintain blood glucose levels during fasting and starvation. - It contains all the necessary enzymes, including **glucose-6-phosphatase**, to convert precursors like lactate, amino acids, and glycerol into glucose. *Kidney* - The **kidney** becomes a significant site of **gluconeogenesis** during prolonged fasting, contributing up to 10-20% of the body's glucose production. - Renal gluconeogenesis primarily utilizes **lactate** and **glutamine** as substrates. *Gut* - The **small intestine (gut)** has been identified as a site of **gluconeogenesis**, particularly following a meal rich in protein. - Its contribution is relatively smaller compared to the liver but plays a role in **postprandial glucose homeostasis**.
Explanation: ***Pasteur effect*** - The **Pasteur effect** describes the phenomenon where the rate of **glycolysis** is inhibited when **oxygen** is available (aerobic conditions). - This inhibition occurs because **oxidative phosphorylation** is more efficient at generating ATP, leading to reduced reliance on glycolysis for energy production. *Crabtree phenomenon* - The **Crabtree phenomenon** is the opposite of the Pasteur effect, where high concentrations of **glucose** inhibit oxygen consumption in the presence of oxygen. - This is primarily observed in some **cancer cells** and yeast, leading to increased glycolysis even under aerobic conditions. *Lewis phenomenon* - The **Lewis phenomenon** (also known as the hunting reaction) refers to the cyclical vasodilation and constriction of peripheral blood vessels in response to **cold exposure**. - It's a physiological response to protect tissues from **frostbite** and is not related to glycolysis or oxygen supply. *None of the options* - This option is incorrect as the phenomenon described, inhibition of glycolysis by increased O2, is a well-established biochemical process known as the **Pasteur effect**.
Explanation: ***55*** - A food is classified as having a **low glycemic index (GI)** if its GI value is **55 or less**. - The GI scale classifies foods as: **low GI (≤55), medium GI (56-69), and high GI (≥70)**. - This classification indicates that the food causes a slower and lower rise in blood glucose levels compared to high or medium GI foods. *25* - This value is well below the threshold for a low GI food and is not the maximum value for this classification. - While a food with a GI of 25 would indeed be considered low GI, the question asks for the **maximum value** that still falls within this category. *45* - This value is still within the low GI range, but it is not the maximum value for this classification. - Foods with a GI up to 55 are considered low GI. *65* - A GI value of 65 falls into the **medium glycemic index** category (GI 56-69). - Therefore, this value classifies a food as medium GI, not low GI.
Explanation: ***Fluoroacetate*** - **Fluoroacetate** is not a direct inhibitor of glycolysis. Instead, it is metabolized to **fluorocitrate**, which then acts as an inhibitor of **aconitase** in the **Krebs cycle (TCA cycle)**, thereby affecting cellular respiration at a later stage. - Its primary role in metabolic inhibition is within the **mitochondria**, impacting energy production via the TCA cycle rather than the glycolytic pathway. *Fluoride* - **Fluoride** is a known inhibitor of **enolase**, an enzyme in the penultimate step of glycolysis. - It forms a complex with **magnesium** and **phosphate** to block the active site of enolase, preventing the conversion of 2-phosphoglycerate to phosphoenolpyruvate. *Arsenite* - **Arsenite** inhibits glycolysis by targeting enzymes containing **sulfhydryl (–SH) groups**, particularly **glyceraldehyde-3-phosphate dehydrogenase (GAPDH)**, a critical enzyme in the glycolytic pathway. - It also inhibits the **pyruvate dehydrogenase complex** (linking glycolysis to the TCA cycle) and TCA cycle enzymes like **α-ketoglutarate dehydrogenase**, thereby affecting multiple stages of cellular respiration. *Iodoacetate* - **Iodoacetate** is a potent inhibitor of the enzyme **glyceraldehyde-3-phosphate dehydrogenase (GAPDH)**. - It specifically alkylates the **cysteine residue** at the active site of GAPDH, preventing the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, thereby blocking glycolysis.
Carbohydrate Chemistry and Classification
Practice Questions
Glycolysis: Reactions and Regulation
Practice Questions
Gluconeogenesis: Reactions and Regulation
Practice Questions
Glycogen Metabolism: Synthesis and Breakdown
Practice Questions
Glycogen Storage Diseases
Practice Questions
Pentose Phosphate Pathway
Practice Questions
Metabolism of Fructose and Galactose
Practice Questions
Disorders of Fructose and Galactose Metabolism
Practice Questions
Blood Glucose Regulation
Practice Questions
Diabetes Mellitus: Biochemical Aspects
Practice Questions
Glycosylation and Glycoproteins
Practice Questions
Lactose Intolerance and Galactosemia
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free